IBDEI1GU ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23443,1,4,0)
 ;;=4^H83.01
 ;;^UTILITY(U,$J,358.3,23443,2)
 ;;=^5006894
 ;;^UTILITY(U,$J,358.3,23444,0)
 ;;=H83.03^^105^1174^81
 ;;^UTILITY(U,$J,358.3,23444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23444,1,3,0)
 ;;=3^Labyrinthitis, bilateral
 ;;^UTILITY(U,$J,358.3,23444,1,4,0)
 ;;=4^H83.03
 ;;^UTILITY(U,$J,358.3,23444,2)
 ;;=^5006896
 ;;^UTILITY(U,$J,358.3,23445,0)
 ;;=A48.1^^105^1174^85
 ;;^UTILITY(U,$J,358.3,23445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23445,1,3,0)
 ;;=3^Legionella pneumonia/Legionnnaire's
 ;;^UTILITY(U,$J,358.3,23445,1,4,0)
 ;;=4^A48.1
 ;;^UTILITY(U,$J,358.3,23445,2)
 ;;=^68817
 ;;^UTILITY(U,$J,358.3,23446,0)
 ;;=A69.20^^105^1174^86
 ;;^UTILITY(U,$J,358.3,23446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23446,1,3,0)
 ;;=3^Lyme disease, unspecified
 ;;^UTILITY(U,$J,358.3,23446,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,23446,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,23447,0)
 ;;=G03.0^^105^1174^89
 ;;^UTILITY(U,$J,358.3,23447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23447,1,3,0)
 ;;=3^Meningitis,Aseptic
 ;;^UTILITY(U,$J,358.3,23447,1,4,0)
 ;;=4^G03.0
 ;;^UTILITY(U,$J,358.3,23447,2)
 ;;=^268379
 ;;^UTILITY(U,$J,358.3,23448,0)
 ;;=G00.9^^105^1174^90
 ;;^UTILITY(U,$J,358.3,23448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23448,1,3,0)
 ;;=3^Meningitis,Bacterial
 ;;^UTILITY(U,$J,358.3,23448,1,4,0)
 ;;=4^G00.9
 ;;^UTILITY(U,$J,358.3,23448,2)
 ;;=^5003724
 ;;^UTILITY(U,$J,358.3,23449,0)
 ;;=G03.9^^105^1174^87
 ;;^UTILITY(U,$J,358.3,23449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23449,1,3,0)
 ;;=3^Meningitis NOS
 ;;^UTILITY(U,$J,358.3,23449,1,4,0)
 ;;=4^G03.9
 ;;^UTILITY(U,$J,358.3,23449,2)
 ;;=^5003729
 ;;^UTILITY(U,$J,358.3,23450,0)
 ;;=B27.90^^105^1174^92
 ;;^UTILITY(U,$J,358.3,23450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23450,1,3,0)
 ;;=3^Mononucleosis
 ;;^UTILITY(U,$J,358.3,23450,1,4,0)
 ;;=4^B27.90
 ;;^UTILITY(U,$J,358.3,23450,2)
 ;;=^5000578
 ;;^UTILITY(U,$J,358.3,23451,0)
 ;;=A31.0^^105^1174^93
 ;;^UTILITY(U,$J,358.3,23451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23451,1,3,0)
 ;;=3^Mycobacteria, Atypical, Pulmonary
 ;;^UTILITY(U,$J,358.3,23451,1,4,0)
 ;;=4^A31.0
 ;;^UTILITY(U,$J,358.3,23451,2)
 ;;=^5000149
 ;;^UTILITY(U,$J,358.3,23452,0)
 ;;=A15.9^^105^1174^95
 ;;^UTILITY(U,$J,358.3,23452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23452,1,3,0)
 ;;=3^Mycobacterium, Tuberculosis active disease
 ;;^UTILITY(U,$J,358.3,23452,1,4,0)
 ;;=4^A15.9
 ;;^UTILITY(U,$J,358.3,23452,2)
 ;;=^5000066
 ;;^UTILITY(U,$J,358.3,23453,0)
 ;;=A31.8^^105^1174^94
 ;;^UTILITY(U,$J,358.3,23453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23453,1,3,0)
 ;;=3^Mycobacterium, Non-Tuberculosis NEC
 ;;^UTILITY(U,$J,358.3,23453,1,4,0)
 ;;=4^A31.8
 ;;^UTILITY(U,$J,358.3,23453,2)
 ;;=^5000152
 ;;^UTILITY(U,$J,358.3,23454,0)
 ;;=M86.10^^105^1174^101
 ;;^UTILITY(U,$J,358.3,23454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23454,1,3,0)
 ;;=3^Osteomyelitis,Acute NOS
 ;;^UTILITY(U,$J,358.3,23454,1,4,0)
 ;;=4^M86.10
 ;;^UTILITY(U,$J,358.3,23454,2)
 ;;=^5014521
 ;;^UTILITY(U,$J,358.3,23455,0)
 ;;=M86.60^^105^1174^102
 ;;^UTILITY(U,$J,358.3,23455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23455,1,3,0)
 ;;=3^Osteomyelitis,Chronic NOS
 ;;^UTILITY(U,$J,358.3,23455,1,4,0)
 ;;=4^M86.60
 ;;^UTILITY(U,$J,358.3,23455,2)
 ;;=^5014630
 ;;^UTILITY(U,$J,358.3,23456,0)
 ;;=N73.9^^105^1174^108
